🟠 Moderate Evidence
A precision-based randomized controlled trial published in 2024 has demonstrated that personalized magnesium supplementation can increase the abundance of gut bacteria associated with colorectal cancer prevention. The 12-week study of 240 adults with a history of colorectal polyps found that tailoring magnesium intake to lower the dietary calcium-to-magnesium ratio increased protective bacterial species by up to 23%, with effects strongest in women and those without specific genetic variants in the TRPM7 magnesium channel gene.
Key takeaways
- Personalized magnesium supplementation increased Carnobacterium maltaromaticum by 23% in adults with normal magnesium absorption capacity
- Effects were most pronounced in women, suggesting hormonal modulation of magnesium uptake and bacterial response
- The approach reflects a “precision nutrition” model—genetic variants in the TRPM7 magnesium channel determined who benefited most from supplementation
- Long-term follow-up and larger, more diverse trials are needed before clinical implementation
Study at a Glance
| Source | Precision-based RCT (2024) |
| Study type | Double-blind randomized controlled trial |
| Sample size | N = 240 adults |
| Population | Adults with prior history of colorectal polyps |
| Intervention duration | 12 weeks |
| Country | United States (Tennessee) |
Bacterial abundance shifts following personalized magnesium supplementation
Proportional changes in protective bacterial species, stratified by TRPM7 genotype and sex
Source: Precision-based RCT, 2024 | Georgian Medical Journal News
Magnesium as a microbial catalyst: new mechanistic understanding
The study reveals that magnesium functions as a critical cofactor in multiple pathways linking diet, gut bacteria, and cancer prevention. According to the trial, Carnobacterium maltaromaticum produces vitamin D precursors, while Faecalibacterium prausnitzii converts these precursors into active metabolites that activate colonic vitamin D receptors—a mechanism potentially capable of inhibiting early tumor initiation.
The intervention targeted a specific dietary balance: participants received personalized magnesium glycinate supplementation designed to lower their calcium-to-magnesium ratio from a baseline of approximately 3.7:1 to a target of 2.3:1. The TRPM7 magnesium channel gene emerged as a key modulator—individuals with normal variants in this gene showed the greatest increases in protective bacteria, while those carrying other variants showed diminished or absent responses. This finding underscores the importance of precision medicine in nutritional interventions, as a generic magnesium supplement may not benefit all individuals equally.
Sex-specific responses suggest hormonal modulation
A striking observation in the trial was that women showed significantly stronger responses to magnesium supplementation than men. The 23% increase in C. maltaromaticum was particularly pronounced in female participants, suggesting that estrogen or other sex-specific hormonal pathways may regulate magnesium absorption or bacterial response to increased magnesium availability.
This finding aligns with emerging evidence that sex differences in microbiome composition and nutrient metabolism are substantial and clinically significant. The implication is that dietary and supplementation strategies for colorectal cancer prevention may need to be tailored not only by genetics but also by sex, a level of personalization that current clinical guidelines have yet to incorporate systematically. See also our explainer on precision nutrition and microbiome science for broader context on this emerging field.
Study limitations and path forward
Despite its novel findings, the trial carries important limitations. The 12-week intervention period was relatively short—colorectal cancer development unfolds over years or decades, leaving open questions about whether short-term bacterial shifts translate into durable protective effects. Additionally, the study measured relative abundance of bacteria rather than absolute counts, meaning researchers observed proportional shifts within the overall microbial community without determining whether total bacterial biomass or overall ecosystem diversity changed.
The study population was predominantly older White adults from Tennessee, limiting generalizability to other ethnic backgrounds, ages, and geographic contexts. Furthermore, Faecalibacterium prausnitzii abundance increases weakened after correction for multiple statistical comparisons, suggesting this finding may require replication before drawing firm conclusions.
Personalized magnesium supplementation increased protective Carnobacterium maltaromaticum by 23% in participants with normal magnesium absorption capacity, with effects strongest in women—supporting a precision nutrition approach to colorectal cancer prevention.
— Precision-based RCT investigators (2024)
What this means
Frequently asked questions
Should I take magnesium supplements if I have a history of colorectal polyps?
Not necessarily, based on current evidence. This trial is the first to show that personalized magnesium supplementation may alter beneficial bacteria in this population, but the effect was observed only in individuals without certain TRPM7 genetic variants and was strongest in women. Discuss genetic testing and supplementation with your gastroenterologist or oncology team before starting any supplement. Dietary magnesium intake should be optimized first.
What is the difference between magnesium glycinate and other forms of magnesium?
Magnesium glycinate is a form of magnesium bound to the amino acid glycine, often chosen because glycine may itself support gut barrier health. Other forms (citrate, malate, oxide) have different absorption profiles and may produce different gastrointestinal effects. The trial used glycinate specifically; it is unclear whether other forms would produce equivalent bacterial shifts.
Why is the calcium-to-magnesium ratio important for colorectal cancer risk?
The underlying biology is not fully understood, but emerging evidence suggests that excess calcium relative to magnesium may shift the gut microbiome toward less favorable bacterial profiles and impair vitamin D metabolism—a pathway implicated in both colorectal cancer initiation and immune function. Lowering this ratio through magnesium supplementation appears to reverse these shifts in some individuals, particularly women and those with specific genetic backgrounds.
Larger, longer-term randomized trials enrolling more diverse populations and measuring multiple endpoints—including fecal microbiota, serum vitamin D metabolites, rectal histology, and ultimately colorectal cancer incidence—will be essential to determine whether this precision magnesium supplementation approach translates into clinical benefit. In the meantime, individuals with polyp history and their clinicians should weigh this emerging evidence within the context of established colorectal cancer prevention strategies: endoscopic surveillance, physical activity, dietary fiber, limited alcohol, and smoking cessation. See our clinical updates section for the latest colorectal cancer prevention guidelines.
Source: Precision-based RCT on magnesium supplementation and gut microbiome in colorectal cancer prevention (2024)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
